TEVA
Teva Pharmaceutical Industries Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$41.96
+0.26%Forward multiples
Based on analyst estimates
- P/E forward
- 14.30x
- P/E 2026E
- 20.93x
- P/E 2027E
- 13.75x
- P/E 2028E
- 12.26x
- P/S forward
- 2.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- 93.24x
- PEG TTM
- 0.17x
- Price / book
- 6.14x
- Price / sales
- 2.84x
- Price / cash flow
- 27.66x
Enterprise value
- Enterprise value
- $61.9B
- EV / sales
- 3.59x
- EV / EBITDA
- 30.40x
- EV / EBIT
- 34.08x
- Market cap
- $49.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026